Avation’s Executive Chairman on the good working relationship with ATR, adding further growth (LON:AVAP) 9 May 2024
Union Jack Oil Final Dividend for 2023, Reflecting Strong Cash Flow and Positive Business Outlook 20 May 2024
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
Unite Group publishes Scheme Document for Empiric Acquisition and Reports Strong Lettings 9 September 2025
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Avation’s Executive Chairman on the good working relationship with ATR, adding further growth (LON:AVAP) 9 May 2024
Union Jack Oil Final Dividend for 2023, Reflecting Strong Cash Flow and Positive Business Outlook 20 May 2024
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
Unite Group publishes Scheme Document for Empiric Acquisition and Reports Strong Lettings 9 September 2025
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Waters Corporation (WAT): Investor Outlook Highlights Promising 7.49% Upside Potential 22 December 2025
Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 23.2% Revenue Growth 22 December 2025
McKesson Corporation (MCK) Stock Report: Analyst Ratings Highlight a 14.52% Upside Potential 22 December 2025
Penumbra, Inc. (PEN) Stock Analysis: A Healthcare Innovator with a 17.8% Revenue Growth Trajectory 22 December 2025
BeOne Medicines Ltd. (ONC) Stock Analysis: Unpacking a 27% Potential Upside in the Biotech Sector 22 December 2025
Bausch + Lomb Corporation (BLCO) Stock Analysis: A Closer Look at Its Valuation Metrics and Growth Potential 22 December 2025
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 26% Upside Potential Amidst Analyst Confidence 22 December 2025
Regencell Bioscience Holdings (RGC) Stock Analysis: A Healthcare Innovator with a $9.8 Billion Market Cap 22 December 2025
TG Therapeutics, Inc. (TGTX) Stock Analysis: An Investor’s Guide to 42.95% Upside Potential 22 December 2025
Ionis Pharmaceuticals, Inc. (IONS) Stock Report: Analyzing a 10.58% Potential Upside in the Biotech Sector 22 December 2025
Masimo Corporation (MASI) Stock Analysis: A 37% Upside Potential in the Healthcare Sector 22 December 2025
Merit Medical Systems, Inc. (MMSI) Stock Analysis: 18% Upside Potential with Strong Buy Ratings 22 December 2025
Merck & Company, Inc. (MRK) Stock Analysis: Strong Dividend Yield and Analyst Optimism Highlight Investment Potential 22 December 2025
Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Medical Device Market with an 8.9% Potential Upside 22 December 2025
Legend Biotech Corporation (LEGN) Stock Analysis: Exploring the 229.56% Potential Upside in the Biotech Sector 22 December 2025
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring a 45% Potential Upside Amidst Robust Revenue Growth 22 December 2025
Waystar Holding Corp. (WAY) Stock Analysis: A Healthcare Tech Play with 47% Potential Upside 22 December 2025
Option Care Health, Inc. (OPCH) Stock Analysis: A Healthcare Heavyweight with a 12.13% Upside Potential 22 December 2025
Nuvalent, Inc. (NUVL) Stock Analysis: Biotech’s Potential 36.52% Upside Amidst Strong Buy Ratings 22 December 2025
H&T Group plc Long-term pawnbroking growth, short-term cost and retail pressure (VIDEO) 21 February 2024
One Health Group plc : Soaring NHS demand drives continued growth and dividends (VIDEO) 16 February 2024
Smarttech247 Group NoPhish integration with Google Mail an important tool for organisations (VIDEO) 14 February 2024
Dekel Agri-vision Lincoln Moore Discusses a Very Positive Start to the Year (LON:DKL) (VIDEO) 14 February 2024
Vistry Group Plc reports H1 results with debt reduction and affordable housing focus 10 September 2025
Avation’s Executive Chairman on the good working relationship with ATR, adding further growth (LON:AVAP) 9 May 2024
Union Jack Oil Final Dividend for 2023, Reflecting Strong Cash Flow and Positive Business Outlook 20 May 2024
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
